Evidence map›Paper›PMID 27017609›Full record

ArticleFamilial cancer2016

MSI detection and its pitfalls in CMMRD syndrome in a family with a bi-allelic MLH1 mutation.

Aurélia Nguyen, Gaelle Bougeard, Meriam Koob, Marie Pierre Chenard, Anne Schneider, Christine Maugard, Natacha Entz-Werle

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Familial cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Medulloblastoma genomics in the modern molecular era.Brain pathology (Zurich, Switzerland) · 2020
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Aurélia NguyenLaboratoire de Biochimie et de Biologie Moléculaire, CHRU Hautepierre Strasbourg, 1, Avenue Molière, 67098, Strasbourg, France.
Gaelle BougeardInserm U614, Faculté de Médecine, Institut de Recherche Biomédicale, Université de Rouen, 22, Boulevard Gambetta, 76183, Rouen, France.
Meriam KoobDépartement de Radiologie II, CHRU Hautepierre Strasbourg, 1, Avenue Molière, 67098, Strasbourg Cedex, France.
Marie Pierre ChenardLaboratoire d'Anatomie Pathologique, CHRU Hautepierre Strasbourg, 1, Avenue Molière, 67098, Strasbourg, France.
Anne SchneiderLaboratoire de Biochimie et de Biologie Moléculaire, CHRU Hautepierre Strasbourg, 1, Avenue Molière, 67098, Strasbourg, France.
Christine MaugardOncogénétique Moléculaire, Laboratoire de diagnostic génétique, Nouvel Hôpital Civil, 1, place de l'Hôpital, 67091, Strasbourg Cedex, France.
Natacha Entz-WerleEA 3430, Université de Strasbourg, "Progression tumorale et microenvironnement. Approches translationnelles et épidémiologie", 3, Avenue Molière, 67000, Strasbourg, France. Natacha.entz-werle@chru-strasbourg.fr.
Hôpital d'Hautepierre · FRHôpitaux Universitaires de Strasbourg · FRHôpital Civil, Strasbourg · FRInserm · FRUniversité de Strasbourg · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The constitutional MisMatch Repair deficiency (CMMRD) syndrome is one of the inherited cancer predisposition syndromes. More than two-third patients belonging to a CMMRD family are diagnosed mainly in the first decade with brain cancers and/or hematological malignancies. This syndrome is due to bi-allelic germline mutations in genes of the MMR pathway (MLH1, MSH2, MSH6 or PMS2). Our family report begins with the index case presenting initially with a medulloblastoma, which was even the two relapses in complete remission, when she was diagnosed for an AML. She died after bone marrow transplantation from toxicity. The family history was progressively established when her uncle was diagnosed for a colonic cancer and a cousin for a brain tumor. Surprisingly, her father had an atypical sarcoma but her brother also presented a lymphoma followed by a gliomatosis cerebri. A new MLH1 bi-allelic mutation was identified in this family. More than the diagnostic difficulties, this family report illustrates the complexity of the microsatellite instability detection in CMMRD patients, which has to be discussed further to a more accurate diagnosis in the pediatric setting, and address the question of the proper diagnostic tool to use in such genetic background with hypermutated tumors.

Indexed as

Microsatellite InstabilityBrain NeoplasmsChildColorectal NeoplasmsFemaleGerm-Line MutationHumansMaleMutL Protein Homolog 1Neoplastic Syndromes, HereditaryPedigreeMLH1 protein, humanMutL Protein Homolog 1Childhood brain cancersMLH1MMR deficiencyMSI

Identifiers

PMID27017609
OpenAlexW2332872544

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.